Status:
COMPLETED
Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes.
Lead Sponsor:
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
Conditions:
Obesity, Morbid
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate the effect of an increased restrictive factor of one gastric anastomosis (OAGB) using a "FundoRing" fundoplication on metabolic outcomes in type 2 diabetes mell...
Detailed Description
The randomized controlled trial compared two interventional procedures: one group - using the original fundoplication procedure to enhance the restrictive effect and another group without fundoplicati...
Eligibility Criteria
Inclusion
- BMI 25-55 kg/m2
- Patients with Diabetes Mellitus, Type 2
Exclusion
- BMI \<25 and \>55 kg/m2
- Patients without Diabetes Mellitus, Type 2
- History of surgery on the stomach
- Less than 18 or more than 60 years of age
- Psychiatric illness
- Patients unwilling or unable to provide informed consent
Key Trial Info
Start Date :
January 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06176443
Start Date
January 13 2020
End Date
May 1 2024
Last Update
November 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oral Ospanov
Astana, Aqmola, Kazakhstan, 010000